ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s other expenses for the three months ended in Jun. 2013 was $-95.0 Mil. Its other expenses for the trailing twelve months (TTM) ended in Jun. 2013 was $-266.7 Mil.
Other Expenses incurred by banks.
Onyx Pharmaceuticals, Inc. Other Expenses for the trailing twelve months (TTM) ended in Jun. 2013 was -76.926 (Sep. 2012 ) + -15.009 (Dec. 2012 ) + -79.754 (Mar. 2013 ) + -95.042 (Jun. 2013 ) = $-266.7 Mil.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data